… patients with frail, we found NOACs outperformed warfarin concerning CVD, IS, SE, MB,
and ICH. Furthermore, our study revealed NOACs had … with frailty and worse outcomes [Citation…

… to warfarin, … patients even had lower rates of unwanted outcomes which is in contrast with
our findings. It should be noted however that dabigatran was given to only 10.1% of patients in …

… (NOACs) in medical patients with atrial fibrillation and … Although these trials demonstrated
no worse outcomes in major … our outcomes, although baseline comparison of NOAC and …

… Alternatively, for warfarin users whose anticoagulation … use NOAC should be considered to
improve patient outcomes. … The most likely explanation is the poorer control of TTR in warfarin …

… and safety of NOACs versus warfarin in AF … patients with AF, poses challenges, with major
bleeding events associated with oral anticoagulants serving as markers of worse outcomes…

… with similar characteristics, the use of antiplatelets was associated with worse clinical outcomes
and higher all-cause mortality compared with OACs. In addition, the limited availability of …

… have not been well described, particularly in Asians. We aimed to assess the clinical outcomes
of NOACs compared with warfarin for … a higher risk of thromboembolic events and worse …

… Outcomes of patients on new oral anticoagulant (NOAC) therapy were compared to respective
outcomes of patients on Coumadin… Coumadin, patients on NOAC have significantly worse …

… outcomes of NOACs versus warfarin in AF patients. AF patients with concomitant PAD may
have a worse … Our findings showed that NOACs had similar efficacy and safety outcomes …

… trials of novel oral anticoagulant (NOAC) have shown … Because there are three outcomes
in this study, if a person died … to progression of HF and worsen outcomes, whereas with lower …